SEC Form 4 · accession 0001209191-17-057639
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J Yeaman
Officer — President and CEO · Director
Period of report
Oct 18, 2017
Accepted (ET)
Oct 20, 2017 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Oct 18, 2017 | M | 30,000 | $28.66 | A | 117,895 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common Stock | Oct 18, 2017 | S | 30,000 | $60.00 | D | 87,895 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $28.66 | Oct 18, 2017 | M | 30,000 | D | — | Mar 16, 2019 | Class A Common Stock | 30,000 | 12,655 | I |
Explanation of responses
- F1This option was granted for a total of 134,757 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of March 16, 2009, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.